Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 1, 2002Diabetes Technology & Therapeutics

Oral Insulin Product Hexyl-Insulin Monoconjugate 2 (HIM2) in Type 1 Diabetes Mellitus: The Glucose Stabilization Effects of HIM2

View Full Paper
Ask AI
Bookmark
Share

Authors

SCStephen ClementInova Fairfax HospitalJSJames StillAtrium Health Wake Forest BaptistGKGordana KosuticUCB Pharma (United States)

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Clement et al. (2002) studied this question.

synapsesocial.com/papers/6ab8c8ddaba944ecbed20583https://doi.org/10.1089/152091502760306544
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Preventive effects of octreotide (SMS 201‐995) on diabetic ketogenesis during insulin withdrawal.1991 · 11 citations
  2. 2“Normal” Insulin Secretion: The Goal of Artificial Insulin Delivery Systems?1980 · 40 citations
  3. 3Direct Measurement of Pulsatile Insulin Secretion from the Portal Vein in Human Subjects12000 · 165 citations
  4. 4The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus1993 · 24,816 citations